BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 20.35
-0.35 (-1.69%)
Jul 30, 2026, 1:30 PM CST
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 2.75 billion as of July 29, 2026. Its market cap has decreased by -34.04% in one year.
Market Cap
2.75B
Enterprise Value
1.79B
Revenue
8.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.35
ChartMarket Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 2.75B, an increase of 55.92%. That is a compound annual growth rate of 11.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 2.75B | -30.52% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sagittarius Life Science | 3.22B |
| SYN-TECH Chem. & Pharm. | 3.21B |
| Apex Biotechnology | 3.20B |
| Shine-On BioMedical | 3.13B |
| 3D Global Biotech | 3.09B |
| Intech Biopharm | 2.76B |
| Energenesis Biomedical CO.,LTD. | 2.66B |
| Great Novel Therapeutics Biotech & Medicals | 2.62B |